"But he is still hoping for one more successful investment — from a remaining, sizable stake in Intellect Neurosciences. The company has a market valuation of only $1.5 million. But Mr. Blech said that if a drug for Alzheimer’s disease showed some promise in animal testing, Intellect could be acquired for a much larger sum."
Oh my..just imagine Pfizer informing the Judge about ILNS's largest stake holder, and Federal "guest".
Oh yes, Maza nailed it, Pfizer is conspiring to bring INTELLECT down, tee hee hee.